Prostate Cancer

The Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging in Primary and Recurrent Prostate Cancer: A Systematic Review of the Literature. September 22, 2021

Focal therapy for prostate cancer: Making the punishment fit the crime. September 22, 2021

Gaps in Public Awareness About BRCA and Genetic Testing in Prostate Cancer: Social Media Landscape Analysis. September 22, 2021

Loss of CDCP1 triggers FAK activation in detached prostate cancer cells. September 22, 2021

Scaffold attachment factor B1 regulates androgen degradation pathways in prostate cancer. September 22, 2021

Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Re September 22, 2021

FDA Authorizes Software that Can Help Identify Prostate Cancer September 21, 2021

Prostate Cancer Diffusion-Weighted Magnetic Resonance Imaging: Does the Choice of Diffusion-Weighting Level Matter? September 21, 2021

Physical Activity: A Feasibility Study on Exercise in Men Newly Diagnosed With Prostate Cancer. September 21, 2021

DISCO App: study protocol for a randomized controlled trial to test the effectiveness of a patient intervention to reduce the financial burden of cancer in a diverse patient population. September 21, 2021

Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of Sweden. September 21, 2021

Predicting survival after radical prostatectomy: Variation of machine learning performance by race. September 21, 2021

Employing a mobile health decision aid to improve decision-making for patients with advanced prostate cancer and their decision partners/proxies: the CHAMPION randomized controlled trial study design. September 20, 2021

Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial. September 20, 2021

Pre-therapeutic comparative dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMAI&T in patients with metastatic castration resistant prostate cancer (mCRPC). September 20, 2021

Five-year outcomes of stereotactic body radiation therapy (SBRT) for prostate cancer: the largest experience in China. September 20, 2021

Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancer. September 20, 2021

Risk for stroke and myocardial infarction with abiraterone versus enzalutamide in metastatic prostate cancer patients. September 20, 2021

Usefulness of the prostate health index in predicting the presence and aggressiveness of prostate cancer among Korean men: a prospective observational study. September 20, 2021

SPOP and CHD1 alterations in prostate cancer: Relationship with PTEN loss, tumor grade, perineural infiltration, and PSA recurrence. September 20, 2021

Page 1 of 1175